Chinese Journal of Dermatology ›› 2013, Vol. 46 ›› Issue (3): 210-212.
• Reviews • Previous Articles Next Articles
SHU Dan1,
Received:2012-02-17
Revised:2012-07-12
Online:2013-03-15
Published:2013-03-01
SHU Dan. Treatment of psoriasis in children[J].Chinese Journal of Dermatology, 2013, 46(3): 210-212.
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
| 1. Chiam LY, de Jager ME, Giam YC, et al. Juvenile psoriasis in European and Asian children: similarities and differences. Br J Dermatol. 2011; 164(5):1101-1103. 2. Fan X, Xiao FL, Yang S, et al. Childhood psoriasis: a study of 277 patients from China. J Eur Acad Dermatol Venereol. 2007; 21(6):762-765. 3. G?nemo A, Wahlgren CF, Svensson ?. Quality of life and clinical features in Swedish children with psoriasis. Pediatr Dermatol. 2011; 28(4):375-379. 4. Tollefson MM, Crowson CS, McEvoy MT, et al. Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2010; 62(6):979-987. 5. Lebwohl M. The role of salicylic acid in the treatment of psoriasis. Int J Dermatol ,1999,38(1):16-24 6. Alora-Palli MB, Perkins AC, Van Cott A, et al. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream. Am J Clin Dermatol. 2010;11(4):275-283. 7. Zvulunov A, Anisfeld A, Metzker A. Efficacy of short-contact therapy with dithranol in childhood psoriasis. Int J Dermatol. 1994; 33(11):808-810. 8. Cornell RC. Clinical trials of topical corticosteroids in psoriasis:correlations with the vasoconstrictor assay. Int J Dermatol.1992;31(Suppl 1):38-40. 9. Feldman SR. Tachyphylaxis to topical corticosteroids: the more you use them, the less they work. Clin Dermatol 2006; 24(3): 229–230. 10. Darley CR, Cunliffe WJ, Green CM, et al. Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris. Br J Dermatol 1996;135(3):390-393. 11. Park SB, Suh DH, Youn JI. A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis. Pediatr Dermatol. 1999; 16(4):321-325. 12. Molin L, Cutler TP, Helander I, et al. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.Br J Dermatol. 1997; 136(1):89-93. 13. Dilurio L, Campione E, Patern EJ, et a1. Childhood nail psoriasis：a useful treatment with tazurotene 0.05％. Pediatr Dermatol 2007;24(3):332-333. 14. Brune A, Miller DW, Lin P, et al. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr Dermatol. 2007; 24(1):76-80. 15. Mansouri P, Farshi S. Pimecrolimus 1 percent cream in the treatment of psoriasis in a child. Dermatol Online J 2006;12(2):7. 16. Nijsten TE, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen ultraviolet A: A cohort study. J Invest Dermatol 2003;121(2):252-258. 17. Collin B, Vani A, Ogboli M, Moss C. Methotrexate treatment in 13 children with severe plaque psoriasis. Clin Exp Dermatol. 2009;34(3):295-298. 18. Inderjeet Kaur, Sunil Dogra, D.N.B., et al. Systemic Methotrexate Treatment in Childhood Psoriasis: Further Experience in 24 Children from India.Pediatric Dermatology. 2008; 25(2): 184–188. 19. Lee JY. Severe 20-nail psoriasis successfully treated by low dose methotrexate. Dermatol Online J, 2009;l5(11):8. 20. Lahdenne P, Rapola J, Ylijoki H, et al. Hepatotoxicity in patients with juvenile idiopathic arthritis receiving longterm methotrexate therapy.J Rheumatol.2002;29(11):2442-2445. 21. Kalb RE, Strober B, Weinstein G, et al. Methotrexate and psoriasis:2009 National Psoriasis Foundation consensus conference. J Am Acad Dermatol.2009;60(5):824-837. 22. Kopp T, Karlhofer F, Szépfalusi Z,et al. Successful use of acitretin in conjunction with narrowband ultraviolet B phototherapy in a child with severe pustular psoriasis Br J Dermatol. 2004;151(4):912-916. 23. Kim HS, Kim GM, Kim SY.Two-stage therapy for childhood generalized pustular psoriasis: low-dose cyclosporin for induction and maintenance with acitretin/narrowband ultraviolet B phototherapy. Pediatr Dermatol. 2006;23(3):306-308. 24. Pereira TM, Vieira AP, Fernandes JC,et al. Cyclosporin A treatment in severe childhood psoriasis. Eur Acad Dermatol Venereol 2006; 20(6):651-656. 25. Harper JI, Ahmed I, Barclay G ,et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol. 2000; 142(1): 52–58. 26. Mahe E, Bodemer C, Pruszkowski A, et al. Cyclosporine in childhood psoriasis. Arch Dermatol 2001;137(11):1532-1533. 27. Patel AM, Moreland LW. Certolizumab pegol: a new biologic targeting rheumatoid arthritis. Expert Rev Clin Immunol. 2010; 6(6):855-866. 28. Paller AS, Siegfried EC, Langley RG, et al. Etanercept treatment for children and adolescents with plaque psoriasis. N Engl Jmed. 2008;358(3):241-251. 29. Hawrot AC, Metry DW, Theos AJ, et a1.Etanercept for psoriasis in the pediatric population: experience in nine patients. Pediatr Dermatol.2006;23(1):67-71. 30. Fabrizi G, Guerriero C, Pagliarello C.Etanercept in infants: suberythrodermic, recalcitrant psoriasis in a 22 month-old child successfully treated with etanercept. Eur J Dermatol. 2007;17(3):245. 31. Lovell DJ, Giannini EH, Reiff A, et al. Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum. 2003; 48(1):218-26. 32. Lovell DJ, Reiff A, Ilowite NT, et al: Safety and ef?cacy of up to eight years with continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2008; 58(5):1496-1504. 33. Menter MA, Cush JM. Successful treatment of pediatric psoriasis with in?iximab. Pediatr Dermatol.2004; 21(1):87-88. 34. Pereira TM, Vieira AP, Fernandes JC, et al. Anti-TNF alpha therapy in childhood pustular psoriasis. Dermatology.2006; 213(4):350-352. 35. Farnsworth NN, George SJ, Hsu S. Successful use of in?iximab following a failed course of etanercept in a pediatric patient. Dermatol Online J.2005; 11(3):11. 36. Hyams JS, Lere MS, Grif?ths A, et al: Long-term outcome of maintenance in?iximab therapy in children with Crohn’s disease. In?amm Bowel Dis.2009; 15(6):816-822. 37. Parslew R, Trauslen J. Efficacy and local safety of a calcipotriol/betamethasone dipropionate ointment in elderly patientswith psoriasis vulgaris. Eur J Dermatol 2005; 15(1):37-39. 38. Osmancevic A, Landin-Wilhelmsen K, Larko O, et al. UVB therapy increases 25(OH) vitamin D syntheses in postmenopausal women with psoriasis. Photodermatol Photoimmunol Photomed 2007; 23(5):172-178. 39. Fairris GM, Dewhurst AG, White JE, Campbell MJ. Methotrexate dosage in patients aged over 50 with psoriasis. BMJ 1989; 298: 801-802. 40. Prodanovich S, Ma F, Taylor JR, et al. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 2005; 52(2):262-267. 41. Gottlieb AB, Boehncke WH, Darif M. Safety and efficacy of alefacept in elderly and other special populations. J Drugs Dermatol 2005; 4(6):718-724. 42. Militello G, Xia A, Stevens SR, et al. Etanercept for the treatment of psoriasis in the elderly. J Am Acad Dermatol 2006; 55(3):517-519. 43. Grozdev IS, Van Voorhees AS, Gottlieb AB, et al. Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2011; 65(3):537-545. |
| [1] | WHANG Baoxi. Advances in the treatment of acne inversa [J]. Chinese Journal of Dermatology, 2013, 46(7): 517-519. |
| [2] | xian-biao ZOU. Diagnosis and treatment of nail psoriasis [J]. Chinese Journal of Dermatology, 2013, 46(3): 213-215. |
| [3] | . Continuing medical education [J]. Chinese Journal of Dermatology, 2012, 45(4): 296-298. |
|
